EUVIMEDEUVIMED entdecken
Crossref

Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients

M Peng, M Wang, X Yang, Y Wang, L Xie, W An, F Ge, C Yang, K Wang

Clinical Radiology · 2025

DOI: 10.1016/j.crad.2025.106915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Radiology, 2025. Verfasst von M Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: PET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China. Electronic address: pmy18846410991…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Positron Emission Tomography Computed Tomography, B7-H1 Antigen, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To develop a positron emission tomography/computed tomography (PET/CT)-based radiomics model for predicting programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients and estimating progression-free survival (PFS) and overall survival (OS) in PD-L1-positive patients undergoing first-line immunotherapy. MATERIALS AND METHODS: We retrospectively analysed 143 NSCLC patients who underwent pretreatment 18F-fluorodeoxyglucose (18F-FDG) PET/CT scans, of whom 86 were PD-L1-positive. Clinical data collected included gender, age, smoking history, Tumor-Node-Metastases (TNM) staging system, pathologic types, laboratory parameters, and PET metabolic parameters. Four machine learning algorithms-Bayes, logistic, random forest, and Supportsupport vector machine (SVM)-were used to build models. The predictive performance was validated using receiver operating characteristic (ROC) curves. Univariate and multivariate Cox analyses identified independent predictors of OS and PFS in PD-L1-positive expression patients undergoing immunotherapy, and a nomogram was created to predict OS. RESULTS: A total of 20 models were built for predicting PD-L1 expression. The clinical combined PET/CT radiomics model based on the SVM algorithm performed best (area under curve for training and test sets: 0.914 and 0.877, respectively). The Cox analyses showed that smoking history independently predicted PFS. SUVmean, monocyte percentage and white blood cell count were independent predictors of OS, and the nomogram was created to predict 1-year, 2-year, and 3-year OS based on these three factors. CONCLUSION: We developed PET/CT-based machine learning models to help predict PD-L1 expression in NSCLC patients and identified independent predictors of PFS and OS in PD-L1-positive patients receiving immunotherapy, thereby aiding precision treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungPositron Emission Tomography Computed TomographyB7-H1 AntigenLung NeoplasmsImmunotherapyHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisFluorodeoxyglucose F18AdultRadiopharmaceuticalsAged, 80 and overMachine LearningRadiomics

Substanzen

B7-H1 AntigenCD274 protein, humanFluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • PET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China. Electronic address: pmy18846410991@163.com.
  • PET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China. Electronic address: wangmenglu0930@163.com.
  • PET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China. Electronic address: yxy21328@163.com.
  • Scientific Research Center Department, Beijing General Electric Company, No.2 Yongchang North Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 102200, China. Electronic address: wang…
  • MR Research China, GE Healthcare, Beijing, 100176, China. Electronic address: lizhixie@gehealthcare.com.
  • Department of Urology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: awx1999@163.com.

Zitieren

APA

Peng, M., Wang, M., Yang, X., Wang, Y., Xie, L., An, W., Ge, F., Yang, C., & Wang, K. (2025). Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clinical Radiology. https://doi.org/10.1016/j.crad.2025.106915

Vancouver

Peng M, Wang M, Yang X, Wang Y, Xie L, An W, et al. Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clinical Radiology. 2025. doi:10.1016/j.crad.2025.106915

BibTeX
@article{Peng2025,
  author = {Peng, M and Wang, M and Yang, X and Wang, Y and Xie, L and An, W and Ge, F and Yang, C and Wang, K},
  title = {Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients},
  journal = {Clinical Radiology},
  year = {2025},
  doi = {10.1016/j.crad.2025.106915}
}
Kostenlos starten →